Content Hub

3rd Cell Therapy Potency Assay Summit FDA Commentary

FDA Commentary:

Hear the perspectives of Health Canada, Takeda, Avobis Bio, Atara Biotherapeutics and University of Ferrera regarding the latest FDA guidance, 

DOWNLOAD